NASDAQ:BTSG • US10950A1060
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BRIGHTSPRING HEALTH SERVICES (BTSG).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-19 | BTIG | Reiterate | Buy -> Buy |
| 2026-03-18 | Mizuho | Maintains | Outperform -> Outperform |
| 2026-03-18 | UBS | Maintains | Buy -> Buy |
| 2026-03-04 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2026-03-03 | Mizuho | Maintains | Outperform -> Outperform |
| 2026-03-02 | BTIG | Reiterate | Buy -> Buy |
| 2026-03-02 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-02-02 | BTIG | Maintains | Buy -> Buy |
| 2026-01-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-23 | BTIG | Maintains | Buy -> Buy |
| 2025-12-18 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-12-12 | Keybanc | Upgrade | Sector Weight -> Overweight |
| 2025-12-11 | Stephens & Co. | Initiate | Overweight |
| 2025-12-09 | B of A Securities | Maintains | Buy -> Buy |
| 2025-12-08 | William Blair | Initiate | Outperform |
| 2025-11-13 | BMO Capital | Initiate | Outperform |
| 2025-11-12 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-29 | BTIG | Maintains | Buy -> Buy |
| 2025-10-29 | UBS | Maintains | Buy -> Buy |
| 2025-10-17 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-10-14 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-10-13 | UBS | Maintains | Buy -> Buy |
| 2025-10-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-09-10 | B of A Securities | Maintains | Buy -> Buy |
| 2025-05-13 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 8.826B 14.32% | 10.072B 14.12% | 12.911B 28.18% | 15.028B 16.40% | 16.859B 12.18% | 20.276B 20.27% | 23.444B 15.62% | 28.443B 21.32% | |
| EBITDA YoY % growth | 349.516M -19.22% | 312.436M -10.61% | 459.529M 47.08% | 769.85M 67.53% | 874.42M 13.58% | 1.022B 16.88% | 1.367B 33.76% | 1.633B 19.46% | |
| EBIT YoY % growth | 147.18M -35.64% | 107.954M -26.65% | 295.252M 173.50% | 544.83M 84.53% | 632.14M 16.03% | 801.09M 26.73% | 1.081B 34.94% | 1.338B 23.77% | |
| Operating Margin | 1.67% | 1.07% | 2.29% | 3.63% | 3.75% | 3.95% | 4.61% | 4.70% | |
| EPS YoY % growth | N/A | 0.55 234.80% | 1.13 105.45% | 1.39 22.73% | 1.72 24.19% | 2.16 25.16% | 3.64 68.93% | 5.26 44.54% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.30 55.27% | 0.32 47.10% | 0.35 -11.08% | 0.40 21.32% | 0.32 8.05% | 0.35 8.74% | 0.40 16.18% | 0.45 11.46% |
| Revenue Q2Q % growth | 3.442B 19.59% | 3.688B 17.16% | 3.889B 16.64% | 3.977B 12.01% | 3.738B 8.60% | 4.081B 10.66% | 4.28B 10.05% | 4.353B 9.45% |
| EBITDA Q2Q % growth | 169.59M 82.35% | 181.83M 37.17% | 187.2M -11.95% | 203.94M -25.13% | 179.37M 5.77% | 194.59M 7.02% | 210.85M 12.63% | 227.84M 11.72% |
| EBIT Q2Q % growth | 123.17M 142.27% | 142.98M 194.46% | 147.62M 68.05% | 163.4M 51.14% | 141.62M 14.98% | 147.47M 3.14% | 163.95M 11.06% | 180.76M 10.62% |
All data in USD
22 analysts have analysed BTSG and the average price target is 45.36 USD. This implies a price increase of 6.67% is expected in the next year compared to the current price of 42.52.
BRIGHTSPRING HEALTH SERVICES (BTSG) will report earnings on 2026-04-30, before the market open.
The consensus EPS estimate for the next earnings of BRIGHTSPRING HEALTH SERVICES (BTSG) is 0.3 USD and the consensus revenue estimate is 3.44B USD.
The consensus rating for BRIGHTSPRING HEALTH SERVICES (BTSG) is 86.3636 / 100 . This indicates that analysts generally have a positive outlook on the stock.